Last reviewed · How we verify

Lumbar Interbody Fusion with Autograft

Mesoblast, Ltd. · Phase 2 active Biologic

Lumbar Interbody Fusion with Autograft is a Biologic drug developed by Mesoblast, Ltd.. It is currently in Phase 2 development. Also known as: Spinal Fusion, Control.

At a glance

Generic nameLumbar Interbody Fusion with Autograft
Also known asSpinal Fusion, Control
SponsorMesoblast, Ltd.
ModalityBiologic
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lumbar Interbody Fusion with Autograft

What is Lumbar Interbody Fusion with Autograft?

Lumbar Interbody Fusion with Autograft is a Biologic drug developed by Mesoblast, Ltd..

Who makes Lumbar Interbody Fusion with Autograft?

Lumbar Interbody Fusion with Autograft is developed by Mesoblast, Ltd. (see full Mesoblast, Ltd. pipeline at /company/mesoblast-ltd).

Is Lumbar Interbody Fusion with Autograft also known as anything else?

Lumbar Interbody Fusion with Autograft is also known as Spinal Fusion, Control.

What development phase is Lumbar Interbody Fusion with Autograft in?

Lumbar Interbody Fusion with Autograft is in Phase 2.

Related